Alex Treiger Grupenmacher

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

Amreena Suri, Anders W. Bailey, Maurício T. Tavares et al. · International Journal of Molecular Sciences · 2019 · 46 citations · Full text

Brain Exposure, Glioma, Tumor Biology +18

Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis

João Paulo Fernandes Felix, Rodrigo Pessoa Cavalcanti Lira, Alex Treiger Grupenmacher et al. · American Journal of Ophthalmology · 2020 · 35 citations

Ocular Disease, Ophthalmology, Glaucoma +4

Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery

Marina Roizenblatt, Vitor Dias Gomes Barrios Marin, Alex Treiger Grupenmacher et al. · JAMA Ophthalmology · 2020 · 23 citations · Full text

Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK)

Alex Treiger Grupenmacher, Abby L. Halpern, Maria de Fátima Bonaldo et al. · Child s Nervous System · 2013 · 22 citations

Malignant Rhabdoid Tumors, Malignant Disease, Medicine +8